-
Loading metrics
Open Access
Peer-reviewed
Research Article
Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya
-
Bernhards R. Ogutu ,
* E-mail: bogutu@wrp-ksm.org
Affiliation US Army Medical Research Unit-Kenya and the Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Odika J. Apollo,
Affiliation US Army Medical Research Unit-Kenya and the Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Denise McKinney,
Affiliation US Army Medical Research Unit-Kenya and the Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Willis Okoth,
Affiliation US Army Medical Research Unit-Kenya and the Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Joram Siangla,
Affiliation US Army Medical Research Unit-Kenya and the Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Filip Dubovsky,
Affiliation The PATH Malaria Vaccine Initiative, Bethesda, Maryland, United States of America
⨯ -
Kathryn Tucker,
Affiliation Statistics Collaborative, Inc., Washington, D. C., United States of America
⨯ -
John N. Waitumbi,
Affiliation US Army Medical Research Unit-Kenya and the Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Carter Diggs,
Affiliation Malaria Vaccine Development Program, US Agency for International Development, Washington, D. C., United States of America
⨯ -
Janet Wittes,
Affiliation Statistics Collaborative, Inc., Washington, D. C., United States of America
⨯ -
Elissa Malkin,
Affiliation The PATH Malaria Vaccine Initiative, Bethesda, Maryland, United States of America
⨯ -
Amanda Leach,
Affiliation GlaxoSmithKline Biologicals s.a., Rixensart, Belgium
⨯ -
Lorraine A. Soisson,
Affiliation Malaria Vaccine Development Program, US Agency for International Development, Washington, D. C., United States of America
⨯ -
Jessica B. Milman,
Affiliation The PATH Malaria Vaccine Initiative, Bethesda, Maryland, United States of America
⨯ -
Lucas Otieno,
Affiliation US Army Medical Research Unit-Kenya and the Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Carolyn A. Holland,
Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
Mark Polhemus,
Affiliation US Army Medical Research Unit-Kenya and the Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Shon A. Remich,
Affiliation US Army Medical Research Unit-Kenya and the Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Christian F. Ockenhouse,
Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
Joe Cohen,
Affiliation GlaxoSmithKline Biologicals s.a., Rixensart, Belgium
⨯ -
W. Ripley Ballou,
Affiliation GlaxoSmithKline Biologicals s.a., Rixensart, Belgium
⨯ -
Samuel K. Martin,
Affiliation US Army Medical Research Unit-Kenya and the Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya
⨯ -
Evelina Angov,
Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
V. Ann Stewart,
Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
Jeffrey A. Lyon,
Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
D. Gray Heppner Jr,
Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
Mark R. Withers,
Affiliation US Army Medical Research Unit-Kenya and the Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya
⨯ - [ ... ],
- for the MSP-1 Malaria Vaccine Working Group
- [ view all ]
- [ view less ]
Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya
- Bernhards R. Ogutu,
- Odika J. Apollo,
- Denise McKinney,
- Willis Okoth,
- Joram Siangla,
- Filip Dubovsky,
- Kathryn Tucker,
- John N. Waitumbi,
- Carter Diggs,
- Janet Wittes
- Published: March 5, 2009
- https://doi.org/10.1371/journal.pone.0004708